Correlation Between Cullinan Oncology and Mersana Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Mersana Therapeutics, you can compare the effects of market volatilities on Cullinan Oncology and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Mersana Therapeutics.

Diversification Opportunities for Cullinan Oncology and Mersana Therapeutics

CullinanMersanaDiversified AwayCullinanMersanaDiversified Away100%
0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Cullinan and Mersana is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Mersana Therapeutics go up and down completely randomly.

Pair Corralation between Cullinan Oncology and Mersana Therapeutics

Given the investment horizon of 90 days Cullinan Oncology LLC is expected to under-perform the Mersana Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cullinan Oncology LLC is 3.55 times less risky than Mersana Therapeutics. The stock trades about -0.64 of its potential returns per unit of risk. The Mersana Therapeutics is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  59.00  in Mersana Therapeutics on November 30, 2024 and sell it today you would lose (9.00) from holding Mersana Therapeutics or give up 15.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Cullinan Oncology LLC  vs.  Mersana Therapeutics

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -60-40-20020
JavaScript chart by amCharts 3.21.15CGEM MRSN
       Timeline  
Cullinan Oncology LLC 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb910111213
Mersana Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Mersana Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb0.511.522.53

Cullinan Oncology and Mersana Therapeutics Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-5.36-4.01-2.67-1.34-0.02241.12.233.364.495.63 0.0050.0100.0150.0200.0250.0300.0350.040
JavaScript chart by amCharts 3.21.15CGEM MRSN
       Returns  

Pair Trading with Cullinan Oncology and Mersana Therapeutics

The main advantage of trading using opposite Cullinan Oncology and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.
The idea behind Cullinan Oncology LLC and Mersana Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Transaction History
View history of all your transactions and understand their impact on performance